EMA Maps Global Drug Supply Chain Regulatory Gaps For ICMRA
Executive Summary
Gaps and overlaps in global and regional efforts to protect pharmaceutical supplies from intrusion of fake drugs, manufacturing quality problems and natural disasters are among the issues the European Medicines Agency has identified by mapping international initiatives for the International Coalition of Medicines Regulatory Authorities.
You may also be interested in...
Track and Trace Systems Need Global Alignment, Regulators Urge
International Coalition of Medicines Regulatory Authorities (ICMRA) wants regulators to think globally when designing and implementing track and trace systems so that counterfeit or substandard products identified in one jurisdiction can be tracked and halted at the borders of other countries. Existing systems have been designed with a national or regional focus only.
‘Shadow’ Factory Challenges Continue For US FDA
Agency wants more information about API suppliers as it winds up case against KV Tech for hidden use of Dr. Reddy’s plant and seeks to find disappearing manufacturer of contaminated OTC eye drops.
US FDA, USP Raise Questions About Valisure’s Assertions Of Benzoyl Peroxide’s Benzene Risks
The US drug regulatory authority and standard-setting organization are evaluating the drug-screening venture’s findings regarding stability and potential carcinogenic risks associated with the widely used acne treatment, which includes Rx formulations.